JGV-28857-81908
4 vaccinations
4 coded responses
31 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 641 / MO
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-16
-
2020-12-17
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: Just pain at the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-18
- 2020-12-20
- 2020-12-21
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to workFree text: Nasal congestion, sneezing, rhinorrhea x3 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-22
-
2020-12-23
Survey response — day 7, dose 1MedDRA: Respiratory tract congestion — Feeling: FairFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-30
-
2021-01-06
Dose 2 — Pfizer-BioNTech
- 2021-01-06
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-07
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-15
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-04-07
- 2021-07-07
-
2021-12-31
Dose 3 — Pfizer-BioNTech
- 2022-01-06
- 2022-07-01
-
2022-10-13
Dose 4 — Pfizer-BioNTech
- 2022-10-13
-
2022-10-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend schoolAdult check-in
-
2022-10-15
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-10-17
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Respiratory tract congestion, Upper respiratory tract infection — Feeling: Poor · FeverFree text: URI with cough, congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-20
- 2022-11-05
- 2022-11-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-12-31 | Pfizer-BioNTech | No |
| 4 | 2022-10-13 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Just pain at the injection site
Systemic reaction (other): Nasal congestion, sneezing, rhinorrhea x3 days
Release 1 — day 7, dose 1
Systemic reaction (other): Congestion
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): URI with cough, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
| SRO | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release